First-line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum. First BEAT (Bevacizumab Expanded Access Trial).
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 28 Jan 2017
At a glance
- Drugs Bevacizumab (Primary) ; Antineoplastics; Capecitabine; Fluorouracil; Irinotecan; Oxaliplatin
- Indications Colorectal cancer
- Focus Adverse reactions; Expanded access
- Acronyms BEAT; First-BEAT
- Sponsors Roche
- 02 Aug 2011 New source identified and integrated (European Clinical Trials Database).
- 23 Sep 2009 Results were presented at the Joint 15th European Cancer Conference (ECCO) and the 34th Congress of the European Society for Medical Oncology (ESMO), held in Berlin, Germany.
- 12 Sep 2008 Results for the final overall survival analysis reported at ESMO 2008.